Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
March 19, 2020
Primary Completion Date
April 8, 2020
Study Completion Date
July 1, 2020
Conditions
COVID-19
Trial Locations (1)
75014
Institut Mutualiste Montsouris, Paris
All Listed Sponsors
lead
Institut Mutualiste Montsouris
OTHER
NCT04452617 - Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 | Biotech Hunter | Biotech Hunter